BWC 0977
Alternative Names: BWC-0977Latest Information Update: 27 Aug 2024
At a glance
- Originator BUGWORKS Research
- Class 2 ring heterocyclic compounds; Antibacterials; Ethylamines; Fluorinated hydrocarbons; Ketones; Oxazines; Pyrazines; Quinolines; Small molecules
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Bacterial infections
Most Recent Events
- 13 Jun 2024 Pharmacodynamics data from a preclinical studies in bacterial infections presented at the ASM Microbe 2024 (ASM-2024)
- 12 Apr 2024 Chemical structure information added
- 20 Mar 2024 Bugworks Research terminates phase I trial in Bacterial infections in Australia due to due to CMC challenges (NCT05942820)